US Patent 7645871 Tumor inhibition by modulating sprouty expression of activity
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+403 characters)
Article
Patent abstract
Methods are provided for identifying compounds that decrease the expression or activity of an overexpressed Sprouty protein in certain cancers. Such compounds can be useful for treating cancers in which a Sprouty protein is overexpressed. Also provided are therapeutic formulations and pharmaceutical formulations for treating cancers characterized by overexpression of a Sprouty protein.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07645871 Tumor inhibition by modulating sprouty expression of activity US Patent 7645871 Tumor inhibition by modulating sprouty expression of activity
Infobox
Patent Number
0764587100
Patent Number
764587100
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076458710
Date of Patent
January 12, 2010
0Patent Application Number
121787530
Date Filed
July 24, 2008
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076458710
Date of Patent
January 12, 2010
0Patent Application Number
121787530
Date Filed
July 24, 2008
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07645871 Tumor inhibition by modulating sprouty expression of activity
Infobox
Is a
Patent jurisdiction
Patent number
07645871
Date of patent
January 12, 2010
Patent application number
12178753
Date Filed
July 24, 2008
Patent primary examiner
Find more entities like US Patent 7645871 Tumor inhibition by modulating sprouty expression of activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
